EvlaBio Company
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
.png)
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2022-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
AdBio partners, Boehringer Ingelheim Venture Fund, HTGF (High-Tech Gruenderfonds), Kurma Partners, NRW.Venture
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland